Apoptosis and expression of the proto-oncogenes bcl-2 and p53 and the proliferation factor Ki-67 in human medullary thyroid carcinoma

Endocrine Pathology

Volumn 7, Issue 1, 1996, Pages 37-45

  Wang, Wenliang ^a,b   Johansson, Henry ^a   Bergholm, Ulla ^a   Wilander, Erik ^a   Grimelius, Lars ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; bcl 2; Medullary thyroid carcinoma (MTC); p53; Proliferating factor (Ki 67)

Indexed keywords

EID: 0002591533     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02739913     Document Type: Article

References (42)

1. Chandler D, El-naggar AK, Brisbay S, Redline RW, McDonnell TJ. Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: evidence for the contribution of bcl-2 expression to renal carcinogenesis. Hum Pathol 25:789-796, 1994.
2. Aihara M, Truong LD, Dunn JK, Wheeler TM, Scardino PT, Thompson TC. Frequency of apoptotic bodies positively correlates with gleason grade in prostate cancer. Hum Pathol 25:797-801, 1994.
3. BourhisJ, BosqJ.WilsonGD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eschwege F. Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer 57:458-462, 1994.
4. Cotter TG, Lennon SV, Glynn JG, Martin SJ. Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells. Anticancer Res 10:1153-1160, 1990.
5. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Machinami R. Overexpression of p53 as possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17:375-381, 1993.
6. Gerdes J, Li L, Schlueter C, Duchrow M, Wohlenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad HD. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 138:867-873, 1991.
7. Hague A, Moorghen M, Hicks D, Chapman M, Paraskeva C. bcl-2 expression in human colorectal adenomas and carcinomas. Oncogene 9:3367-3370, 1994.
8. Ito K, Watanabe K, Nasim S, Sasano H, Sato S, Yajima A, Silverberg SG, Garrett CT. Prognostic significance of p53 overexpression in endometrial cancer. Cancer Res 54:4667-4670, 1994.
9. Joensuu H, Pylkkänen L.Toikkanen S. bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994.
10. Kushima R, Moritani S, Hattori T. Over-expression of p53 protein in gastric carcinomas: relationship with development, progression and mucin-histochemical differentiation. Cancer J 7:192-197, 1994.
11. Porter PL, Gown AM, Kramp SG, Coltrera MD. Widespread p53 overexpression in human malignant tumors: an immunohistochemical study using methacam-fixed, embedded tissue. Am J Pathol 140:145-153, 1992.
12. Porter MJ, Field JK, Lee JCK, Leung SF, Lo D, Hasselt CAV. Detection of the tumour suppressor gene p53 in nasopharyngeal carcinoma in Hong Kong Chinese. Anticancer Res 14:1357-1360, 1994.
13. Skalova A, Lehtonen H, Boguslawsky KV, Leivo I. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol 25:929-935, 1994.
14. Teh M, Wee A, Path MRC, RaJu GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 74:1542-1545, 1994.
15. LeBrun DP, Wamke RA, Cleary ML. Expression of bcl-2 fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743-753, 1993.
16. Novack DV, Korsmeyer SJ. bcl-2 protein expression during murine development. Am J Pathol 145:61-73, 1994.
17. Baer R. bcl-2 breathes life into embryogenesis. AmJ Pathol 145:7-10, 1994.
18. Gusterson B, Anbazhagan R, Waren W, Midgely C, Lane P, O'Hare M, Stamps A, Carter R, Jayatilake H. Expression of p53 in pre-malignant and malignant squamous epithelium. Oncogene 6:1785-1789, 1992.
19. Key G, Becker MHG, Baron B, Duchrow M, Schluter C, Flad HD, Gerdes J. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab Invest 68:629-636, 1993.
20. Reinariz JJ, George E, Lindgren BR, Niehans GA. Expression of p53, transforming growth factor alpha, epidermal growth factor recep-tor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known pre-dictors of survival. Hum Pathol 25:1075-1083, 1994.
21. Sasano H, Garrett CT. Oncogenes in gynecological tumors. CurrTop Pathol 85:357-372, 1992.
22. Roncalli M, Viale G, Grimelius L, Johansson H, Wilander E, Alfano RM, Springall D, Battezzati PM, Polak JM, Coggi G. Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma. Cancer 74:134-141, 1994.
23. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992.
24. Rosai J, Carcangiu ML, Delellis RA. Tumors of the thyroid gland. Atlas of tumor pathology. 3rd ser. Washington, DC: Fascicle 5, Armed Forces Institute of Pathology, 1992; 207-240.
25. Bergholm U. Medullary thyroid carcinoma in Sweden. Compr Summ Uppsala Diss Faculty Med 189:1-32, 1989.
26. Quinn CM, Wright NA. The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol 160:93-102, 1990.
27. Duncan AMV, Heddle JA, Blakey DH. Mechanism of induction of nuclear anomalies by γ-radiation in the colonic epithelium of the mouse. Cancer Res 45:250-252, 1985.
28. Lee FD. Importance of apoptosis in the histopathology of drug related lesions in the large intestine. J Clin Pathol 46:118-122, 1993.
29. Willingham MC, Bhalla K. Transient mitotic phase localization of bcl-2 oncoprotein in human carcinoma cells and its possible role in prevention of apoptosis. J Histochem Cytochem 42:441-450, 1994.
30. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer J. bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell 75:241-251, 1993.
31. Pezzella F, Turley H, Kuzu I, Tungekar MF, Dunnill MS, Pierce CB, Harris A, Gatter KC, Mason DY. bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694, 1993.
32. Korsmeyer SJ. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879-886, 1992.
33. Nakagawa K, Yarnamura K, Maeda S, Ichihashi M. bcl-2 expression in epidermal keratinocytic diseases. Cancer 74:1720-1724, 1994.
34. McDonnell TJ, Troncoso P, Brisbay SM, Logothetis C, Chung LWK, Hsieh JT, Tu SM, Campbell ML. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992.
35. Viale G, Roncalli M, Grimelius, Graziani D, Johansson H, Bergholm U. Prognostic value of bcl-2 immunoreactivity in medullary thyroid carcinoma. Hum Pathol 26:945-950, 1995.
36. Kanavaros P, Loannidou D.Tzardi M, Datseris G, Katsantonis J, Delidis G.Tosca A. Mycosis fungoides: expression of C-myc p62, p53, bcl-2 and PCNA proteins and absence of association with Epstein-Barr virus. Pathol Res Pract 190:767-774, 1994.
37. Pezzella F, Morrison H, Jones M, Lane D, Harris AJ, Mason DY. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkins lymphoma. Histopathology 22:39-44, 1993.
38. Marin MC, Hsu B, Meyn RE, Donehower LA, El-naggar AK, McDonnell TJ. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9:3107-3112, 1994.
39. Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 89:4495-4499, 1992.
40. Dobashi Y, Sugimura H, Sakamoto A, Mernyei M, Mori M, Oyama T, Machinami R. Stepwise participation of p53 gene mutation during differentiation of human thyroid carcinomas. Diagn Mol Pathol 3:9-14, 1994.
41. MiyashitaT, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed J. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805, 1994.
42. Pelosi G, Bresaola E, Rodella S, Manfrin E, Piubello Q, Schiavon I, Iannucci A. Expression of proliferation cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: an immunochemical study with clinical, pathological, and histologic correlations. Diagn Cytopathol 11:131-140, 1994.